Pelvic Inflammatory Disease: Clinical Trials

5 trials for Pelvic Inflammatory Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 35Completed 5
Phase 21Completed 1

Follow Pelvic Inflammatory Disease: new trials by email Literature Review of Pelvic Inflammatory Disease trials Research Report on Pelvic Inflammatory Disease

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 3 Study Of Intravenous Metronidazole For Intrabdominal Infection
Metronidazole, Ceftriaxone sodium - Intra-abdominal Infections
Phase 3CompletedPfizer382011-11-012014-01-24
Study Of Azithromycin Intravenous Formulation Against Pelvic Inflammatory Disease (PID) In Japan
Azithromycin - Pelvic Inflammatory Disease
Phase 3CompletedPfizer762009-05-012011-11-03
Antibiotic Prophylaxis in Prelabor Rupture of Membranes at Term
Ampicillin + gentamicin - Chorioamnionitis, Puerperal Endometritis
Phase 2 / Phase 3CompletedHospital de Santa Maria, Portugal1612008-10-012016-11-28
A Trial Comparing Moxifloxacin Versus Levofloxacin Plus Metronidazole In Uncomplicated Pelvic Inflammatory Disease
Moxifloxacin (Avelox, BAY12-8039), Levofloxacin & Metronidazole - Pelvic Inflammatory Disease
Phase 3CompletedBayer4602007-01-012014-09-08
Uncomplicated Pelvic Inflammatory Disease. Treatment With Moxifloxacin.
Ofloxacin, Avelox (Moxifloxacin, BAY12-8039) - Pelvic Inflammatory Disease
Phase 3CompletedBayer7492003-04-012014-10-15

Narrower conditions

Chorioamnionitis (1)  ·  Endometritis (1)  ·  Fetal Membranes, Premature Rupture (1)  ·  Intraabdominal Infections (1)  ·  Neonatal Sepsis (1)  ·  Pelvic Infection (1)

Broader conditions

Adnexal Diseases (5)  ·  Female Urogenital Diseases (5)  ·  Female Urogenital Diseases and Pregnancy Complications (5)  ·  Genital Diseases (5)  ·  Genital Diseases, Female (5)  ·  Infections (5)  ·  Urogenital Diseases (5)  ·  Pelvic Infection (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Fetal Diseases (1)  ·  Infant, Newborn, Diseases (1)  ·  Inflammation (1)  ·  Obstetric Labor Complications (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Metronidazole (2)  ·  Moxifloxacin (2)  ·  Ampicillin (1)  ·  Azithromycin (1)  ·  Ceftriaxone (1)  ·  Gentamicins (1)  ·  Levofloxacin (1)  ·  Ofloxacin (1)

Sponsors

Bayer (2)  ·  Pfizer (2)  ·  Hospital de Santa Maria, Portugal (1)

Countries

Japan (2)  ·  China (1)  ·  Denmark (1)  ·  Finland (1)  ·  France (1)  ·  Germany (1)  ·  Greece (1)  ·  Hungary (1)  ·  Indonesia (1)  ·  Italy (1)  ·  Lithuania (1)  ·  Pakistan (1)  ·  Philippines (1)  ·  Poland (1)  ·  Portugal (1)

Top investigators

Filipa Faria Vaz Passos, Dr (1)

Results publications

PMID 20716255, PMID 23090521, PMID 24787738, PMID 25442806